ARTICLE | Clinical News
Zila Pharmaceuticals Inc. regulatory update
May 10, 1993 7:00 AM UTC
Zila Pharmaceuticals Inc. Zila Pharmaceuticals Inc., a division of Zila Inc. (ZILA), said that regulatory authorities in Australia have approved the marketing of OraScan, an oral cancer diagnostic a...